Daratumumab + Hyaluronidase

Daratumumab/hyaluronidase, sold under the brand name Darzalex Faspro, is a fixed-dose combination medication for the treatment of adults with newly diagnosed or relapsed/refractory multiple myeloma.[2][1][3] It is a combination of daratumumab and hyaluronidase.[1] It is administered via subcutaneous injection.[1] The most common adverse reaction using daratumumab/hyaluronidase as monotherapy is upper respiratory t... [wikipedia]